A
Avadel Pharmaceuticals - ADR (AVDL)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Avadel Pharmaceuticals - ADR (AVDL)
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more
- USD10.09
- USD10.39
- USD9.98
- USD17.30
- 4.90%
- 182M
- 977.07k
- 1.56M
- 931M
- 6.38
- -39.50%
- 27.40%
Stock News
1 hour ago
S&P 500 stumbles after hitting intraday high — the downside of a narrow rally
MarketWatch
2 hours ago
Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites
CNBC
3 hours ago
GM expands production of gas-powered SUV, trucks in Michigan
CNBC
3 hours ago
Trump's new trade deal promises billions to the U.S. — plus, reasons behind the mixed market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
